Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Dystrophy With Flecks, Type 1”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Large-scale testing (Phase 3)Looking for participantsNCT07419334
What this trial is testing

Study of ALK-001 on the Progression of Stargardt Disease

Who this might be right for
Stargardt Disease
Alkeus Pharmaceuticals, Inc. 230
Testing effectiveness (Phase 2)Looking for participantsNCT07002398
What this trial is testing

Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)

Who this might be right for
Retinal Dystrophy Due to Biallelic ABCA4 MutationsStargardt Disease 1
VeonGen Therapeutics GmbH 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06300476
What this trial is testing

Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)

Who this might be right for
Stargardt Disease 1
West China Hospital 9
Not applicableLooking for participantsNCT06435000
What this trial is testing

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

Who this might be right for
StargardtStargardt's DiseaseStargardt Disease+1 more
Splice Bio 75
Testing effectiveness (Phase 2)Enrolling By InvitationNCT02402660
What this trial is testing

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more
Alkeus Pharmaceuticals, Inc. 160
Not applicableActive Not RecruitingNCT05674058
What this trial is testing

Function and Imaging Assessments for G1961E-associated Stargardt Disease

Who this might be right for
Stargardt DiseaseStargardt Disease 1Fundus Flavimaculatus+2 more
University Hospital, Basel, Switzerland 20
Testing effectiveness (Phase 2)Looking for participantsNCT06942572
What this trial is testing

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy
Splice Bio 57
Not applicableStudy completedNCT03297515
What this trial is testing

Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease

Who this might be right for
Dry AMDStargardt Disease 1
Ophthalmos Research and Education Institute 32
Not applicableUnknownNCT04281732
What this trial is testing

Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision

Who this might be right for
Low VisionRetinitis PigmentosaStargardt Disease 1+3 more
Queen's University, Belfast 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04239625
What this trial is testing

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more
Alkeus Pharmaceuticals, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06467344
What this trial is testing

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

Who this might be right for
Stargardt DiseaseCone Rod DystrophyJuvenile Macular Degeneration+1 more
Ascidian Therapeutics, Inc 15
Not applicableLooking for participantsNCT06445322
What this trial is testing

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Who this might be right for
Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more
Ascidian Therapeutics, Inc 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06388083
What this trial is testing

Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease

Who this might be right for
STGD1Stargardt Disease 1
Belite Bio, Inc 60
Testing effectiveness (Phase 2)Study completedNCT04489511
What this trial is testing

Study of STG-001 in Subjects With Stargardt Disease

Who this might be right for
Stargardt Disease-1
Stargazer Pharmaceuticals, Inc. 10
Large-scale testing (Phase 3)Study completedNCT05244304
What this trial is testing

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

Who this might be right for
Stargardt Disease 1
Belite Bio, Inc 104
Early research (Phase 1)UnknownNCT03772938
What this trial is testing

Stem Cells Therapy in Degenerative Diseases of the Retina

Who this might be right for
Retinal DegenerationRetinitis PigmentosaAge Related Macular Degeneration+1 more
Pomeranian Medical University Szczecin 30
Testing effectiveness (Phase 2)Study completedNCT03364153
What this trial is testing

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Pharma Global Development, Inc. 121
Testing effectiveness (Phase 2)Looking for participantsNCT07161544
What this trial is testing

AAVB-039 in Participants With Stargardt Disease (STGD1)

Who this might be right for
Stargardt Disease
AAVantgarde Bio Srl 75
Very early researchLooking for participantsNCT07063251
What this trial is testing

An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease

Who this might be right for
Stargardt Disease Type 1 (STGD1)
HuidaGene Therapeutics Co., Ltd. 6
Not applicableUnknownNCT05258032
What this trial is testing

Structural and Functional Characterization of Rare Ocular Diseases

Who this might be right for
Retinitis PigmentosaStargardt Disease 1Best Disease+2 more
Barcelona Macula Foundation 50